COHR股价大涨与2027年强劲需求分析
COHR股价大涨与2027年强劲需求分析
I'll check the current quote and the reported order news first, then the company's filings.
Conclusion: The filings support demand visibility into calendar 2027 and an early contracted ramp into 2028. The "orders extend through 2028" headline is an overstatement, though. Management said orders "increasingly extend into calendar 2028" and that LTAs typically run to the end of the decade. The biggest near-term risks are execution and cash: capex is 33% of revenue, operating cash flow was negative, and a few AI buyers account for the long-dated demand. The stock rallied 16.79% on Monday, November 9, 2026, but the quarter's results alone did not contain a new 2028 commitment.
What moved the stock
- COHR closed at , up , on Monday, November 9, 2026 (regular session, 16:10 ET quote), with market cap of about $44.4B.
- The move came after the November 4 fiscal Q1 2027 report. The primary release and call were the catalysts; the "through 2028" framing came from press coverage of the call.
Demand durability: strong through 2027, early evidence for 2028
- Q1 FY27 revenue was , up year over year and pro forma. Non-GAAP gross margin was , up 184 bps.
- Data center and communications was , up 79%, and is now 82% of revenue (calculated: ). This concentration makes the thesis hinge on AI data-center demand.
- Management said order coverage through calendar 2027 is "exceptional" and that customer orders increasingly extend into 2028, with "no signs of attenuation" ().
- The clearest 2028 item is PhotonLink: a new LTA worth about $20B over five years with a major AI customer, with revenue starting in early calendar 2028. Average annual value is about of annualized Q1 revenue (calculated). That is meaningful but not yet revenue. Management guided PhotonLink to exceed $100M in the March quarter and $250M per quarter before the end of calendar 2027 (transcript prepared remarks).
- Customer concentration is explicit. The 24/7 Wall St. article (secondary) notes that NVIDIA's partnership with Coherent is nonexclusive and that NVIDIA announced a similar arrangement with Lumentum, so orders can shift between suppliers.
Capacity: the core constraint and the largest cash commitment
- Q1 capex was , against a year earlier. That is about (calculated). Management expects capex to rise again sequentially in Q2.
- Internal indium phosphide (InP) output capacity doubled year over year and is on track to more than double again by the end of calendar 2027. Management says the substrates and critical inputs are secured and that it is planning further expansion beyond 2027. The 6-inch lines in Texas and Sweden have yields above the 3-inch lines, and a 6-inch line in Zurich is due in the first half of calendar 2027.
- Management argues the capacity is fungible across product lines. That reduces stranded-asset risk, but it is an assertion, not something the filings quantify.
- Management reports Q1 operating cash flow of . Subtracting capex gives roughly before any other items (calculated, Q1 only).
- Cash was at quarter end versus $2.59B the prior quarter, and the debt leverage ratio was . Long-term debt on the balance sheet rose year over year, so the company is funding capacity partly with borrowing.
Execution risks
- Margin target: Management raised its target to above 45% non-GAAP gross margin before the end of calendar 2028, 300 bps above the target set 18 months earlier. Gains so far came from pricing optimization, input-cost reduction, and yields. Pricing is the most reversible driver if AI-buyer leverage shifts.
- Ramp timing: PhotonLink revenue depends on the early-2028 start, and the first scale-up shipments are expected in the second half of 2027. Any slip moves the 2028 story out.
- Customer and supplier concentration: Demand is concentrated in a few hyperscale and AI buyers. Supplier dual-sourcing by NVIDIA and the shifting of orders are direct risks.
- Capital intensity: Capex is 33% of revenue and rising. If orders slow while capacity keeps expanding, returns on that capex fall and cash burn rises.
- Guidance: The December-quarter guide is $2.55–2.75B revenue and $2.28–2.48 non-GAAP EPS, per the 24/7 Wall St. article. I could not confirm it in the primary release text I retrieved, so treat it as secondary. The guide implies about sequential growth at the midpoint. Reaching the $4B quarter requires about growth from Q1.
- Standard risk factors: The release cites demand changes, tariffs, competition, customer demand estimation, and debt service.
What would change this view
- Confirm Dec-quarter revenue at or above $2.55B and a March-quarter PhotonLink figure above $100M. Either miss would signal that the path to a $4B quarter is slipping.
- Watch whether capex keeps rising while operating cash flow stays negative.
- Watch for any NVIDIA or hyperscaler order shift toward Lumentum.
Data as of: Quote as of the November 9, 2026 close (regular session, 16:10 ET). Company results and call as of November 4, 2026 (fiscal Q1 2027, quarter ended September 30, 2026). The transcript has one garbled reference to "calendar 2025" in the prepared remarks; the same passage and other remarks refer to calendar 2027, which I used.
Sources
- Driven market quotes, COHR, November 9, 2026 close ()
- Coherent Corp., Q1 FY2027 results press release, November 4, 2026 (GlobeNewswire) ()
- Coherent Q1 FY2027 earnings call transcript, November 4, 2026 (Motley Fool) (, )
- Coherent Q1 FY2027 financial tables, cash flow and balance sheet, as published with the release ()
- 24/7 Wall St., "Coherent Now Sees Growth Above 60%…", November 5, 2026 (secondary; used only for the December-quarter guide and the NVIDIA/Lumentum context) ()
- Yahoo Finance, Lumentum CEO comments on sold-out optical parts, October 8, 2026 (context only) (article)